Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Simenepag Isopropyl in Ocular Hypertension or Glaucoma
NCT00809848Phase 2Completed
- Sponsor
- Allergan
- Start
- Feb 2009
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of simenepag isopropyl in ocular hypertension, primary open-angle glaucoma (POAG), sponsored by Allergan. Started Feb 2009; status: completed.
02
Drugs
simenepag isopropyl
03
Conditions
ocular hypertensionprimary open-angle glaucoma (POAG)
Beyond the preview
Go deeper on NCT00809848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00809848.